| | | | | | | |
 | MODERNA, INC. | 8.73% | 8.37% | -41.86% | -17.76% | 576.41% | 58 733 |
 | LONZA GROUP AG | 4.56% | 4.22% | -24.79% | 0.07% | 81.67% | 44 437 |
| IQVIA HOLDINGS INC. | 6.15% | 9.25% | -21.85% | -7.14% | 61.68% | 41 736 |
| SEAGEN INC. | 2.12% | 1.25% | -8.54% | -6.43% | 104.50% | 26 026 |
| ICON PUBLIC LIMITED COMPANY | 4.44% | 5.18% | -26.61% | 1.63% | 61.32% | 18 478 |
 | CELLTRION, INC. | 1.30% | 6.12% | -21.21% | -40.85% | -2.06% | 17 245 |
| ALNYLAM PHARMACEUTICALS, INC. | 1.73% | -2.91% | -24.66% | -8.89% | 85.36% | 15 436 |
| BIO-TECHNE CORPORATION | 5.81% | 5.52% | -25.28% | -5.65% | 95.44% | 15 166 |
 | PHARMARON BEIJING CO., LTD. | 5.45% | -0.10% | -20.79% | -40.99% | 214.24% | 12 484 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 6.17% | 5.06% | -35.13% | -26.43% | 88.15% | 12 417 |
| QIAGEN N.V. | 3.86% | 4.68% | -14.74% | -3.56% | 24.06% | 10 779 |
| UNITED THERAPEUTICS CORPORATION | 4.92% | 25.22% | 9.14% | 26.97% | 169.52% | 10 683 |
| HANGZHOU TIGERMED CONSULTING CO., LTD | 3.85% | -5.76% | -35.56% | -53.85% | 80.62% | 10 252 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | 0.13% | 0.94% | 4.03% | 73.70% | 131.88% | 10 185 |
| SYNEOS HEALTH, INC. | 4.53% | 6.02% | -26.78% | -13.91% | 77.10% | 7 712 |
| | | | | | | |
| | Gemiddelde | 4.25% | 4.87% | -20.97% | -8.21% | 123.33% | |
| | Gewogen gemiddelde per kap. | 5.01% | 5.50% | -24.39% | -9.31% | 177.19% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
